Airway Management Devices Market Report 2026

Airway Management Devices Market Overview

• Airway Management Devices market size has reached to $2.61 billion in 2025 • Expected to grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Surgical Procedure Surge Fuels Growth Of Airway Management Devices Market • Market Trend: Innovations In Airway Management Devices For Enhanced Patient Care • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Airway Management Devices Market?

Airway management devices are medical techniques and tools for preserving or reestablishing a secure, reliable channel for ventilation and oxygenation. Airway management devices are used to prevent and relieve airway obstruction to ensure the proper exchange of air between the patient’s lungs and atmosphere. The main types of airway management devices are infraglottic airway management devices, supraglottic airway management devices, resuscitators, laryngoscopes, and other devices. The infraglottic airway management devices are used to prevent and relieve airway obstruction to ensure the proper exchange of air between the patient’s lungs and atmosphere. These are used for applications such as anesthesia, emergency medicine, and others that are used by hospitals and home care.

What Is The Airway Management Devices Market Growth Forecast?

The airway management devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to technological advancements in video and fiberoptic laryngoscopes, expansion of homecare and portable airway devices, rising emergency and critical care service demand, increasing regulatory compliance and safety standards, integration with smart monitoring and connected healthcare devices. Major trends in the forecast period include increasing adoption of video and fiberoptic laryngoscopes, rising demand for portable and homecare airway devices, expansion of emergency medicine and critical care applications, enhanced focus on patient safety and minimizing airway complications, growth in training and simulation-based airway management.

Global Airway Management Devices Market Segmentation

1) By Type: Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Resuscitators, Laryngoscopes, Other Devices 2) By Application: Anesthesia, Emergency Medicine, Other Applications 3) By End Use: Hospital, Homecare Subsegments: 1) By Infraglottic Airway Management Devices: Endotracheal Tubes, Tracheostomy Tubes, Cuffed Tubes 2) By Supraglottic Airway Management Devices: Laryngeal Mask Airways (LMA), Supraglottic Airway Devices, Oropharyngeal Airways 3) By Resuscitators: Bag-Valve Masks (BVM), Manual Resuscitators, Neonatal Resuscitators 4) By Laryngoscopes: Direct Laryngoscopes, Video Laryngoscopes, Fiberoptic Laryngoscopes 5) By Other Devices: Airway Accessories, Airway Pressure Monitoring Devices, Airway Management Suction Devices

What Is The Driver Of The Airway Management Devices Market?

The rise in surgical procedures is expected to propel the growth of the airway management devices market going forward. A surgical procedure is a medical intervention that involves making an incision with tools, usually done in an operating room, and usually requires anesthetic and/or breathing support. Airway management devices are used in surgical procedures to maintain an open airway and protect the lungs from aspiration of secretions or other fluids. For instance, in June 2024, according to reports published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based non-profit organization, total surgical and non-surgical procedures increased by 3.4% in 2023, up to 34.9 million. Liposuction was the most common surgical procedure in 2023 as in 2022, with more than 2.2 million, followed by breast augmentation, eyelid surgery, abdominoplasty, and rhinoplasty. Therefore, the rise in surgical procedures drives the growth of the airway management devices industry.

Key Players In The Global Airway Management Devices Market

Major companies operating in the airway management devices market are Medtronic PLC, Smiths Medical Inc., Teleflex Incorporated, Ambu A/S, KARL STORZ SE & Co. KG, Flexicare Medical Limited, Intersurgical Ltd., Becton Dickinson and Company, Mercury Medical, Well Lead Medical Co. Ltd., Unomedical Inc., SunMed LLC, Tuoren Medical Device India Pvt. Ltd., Medline Industries Inc., Armstrong Medical Limited, Zhejiang Sujia Medical Device Co.Ltd., Vyaire Medical Inc., Salter Labs Inc., Cook Medical Inc., Olympus Corporation, ICU Medical Inc., VBM Medizintechnik GmbH, Verathon Inc.

Global Airway Management Devices Market Trends and Insights

Major companies operating in the airway management devices market are developing advanced technology, such as medical devices, to enhance patient care, improve airway accessibility, and ensure safer intubation procedures in various clinical settings. Medical devices are instruments, apparatuses, machines, or implants used in healthcare for diagnosing, preventing, monitoring, treating, or alleviating diseases or medical conditions. For instance, in March 2023, BHV Partners, a US-based investment company, launched Conus Airway, a new medical device startup. Conus Airway is dedicated to developing innovative medical devices aimed at enhancing anesthesia and surgical procedures related to the respiratory tract. By focusing on cutting-edge technology and design, Conus Airway seeks to improve patient outcomes and streamline operations in clinical environments. The startup aims to address specific challenges in airway management, ultimately contributing to safer and more effective healthcare solutions for both patients and medical professionals.

What Are Latest Mergers And Acquisitions In The Airway Management Devices Market?

In October 2023, AirLife, a US-based provider of consumable medical devices for anesthesia and respiratory care, acquired Avanos Medical’s respiratory health business for an undisclosed amount. With this acquisition, AirLife aimed to strengthen its product portfolio, expand its manufacturing footprint, and enhance its leadership position in the respiratory and anesthesia consumables market. Avanos Medical’s respiratory health business is a US-based healthcare company that specializes in providing closed suction systems, endotracheal tubes, and airway management consumables.

Regional Outlook

North America was the largest region in the airway management devices market in 2025. Western Europe was the second-largest region in the airway management devices market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Airway Management Devices Market?

The airway management devices market consists of sales of oropharyngeal airway (OPA), nasopharyngeal airway (NPA), and endotracheal airway (ETA). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.